By: Press Release | July 29, 2014
“These guidances will help companies establish clear, well-understood compliance programs so that their relationships with these third-parties will be focused on what is best for patients. MEDEC’s approval of these guidances will help ensure the integrity of medical decision-making and promote further public confidence in our industry.”
By: Statement | July 25, 2014
The Advanced Medical Technology Association (AdvaMed) today issued a statement by Stephen J. Ubl, president and CEO, commending a call by Members of Congress for the Office of the Inspector General (OIG) to study the impact of competitive bidding on patients.
By: Statement | July 22, 2014
“AdvaMed applauds the subcommittee for holding this important hearing on barriers to evidence development and improving communication and collaboration among patients, providers, researchers, and medical technology companies to ensure continued development of the latest treatments and cures.